Activation of this pathway triggers the secretion of IL-6 by TAMs, which then enhances the levels of eukaryotic initiation factor 4A3 (EIF4A3) and the chemokine CCL2 in tumor cells. This evidence concerns the gene IL6 and neoplasm.